OCT 10, 2016 06:39 AM PDT

Protecting B Cell Chromosomes to Treat Non-Hodgkin's Lymphoma

WRITTEN BY: Kara Marker
One small change in the chromosomes of B lymphocytes, and the immune cells cannot proliferate and create antibodies to fight infection and cancer. A recent study shows that the protective abilities of a particular enzyme might be the key to a powerful population of protective B lymphocytes.
An enzyme called uracil-DNA glycosylase (UNG) protects the ends of B cell chromosomes so that the cells can continue to divide and give rise to antibodies to target foreign antigens. Researchers from Rockefeller University believe that promoting this protective mechanism could help treat certain types of non-Hodgkin’s lymphoma in addition to other infections. 

Another enzyme enters the picture once B cells begin proliferating due to a foreign antigen identified in the blood stream. Activation-induced deaminase, or AID, is a DNA-modifying enzyme that triggers mutations in the immunoglobulin genes of B cells that are responsible for the development of an increasingly diverse population of infection-fighting antibodies. This diverse population is particularly capable of strong binding of foreign antigens and the stimulation of various immune responses.

Unfortunately, the AID enzyme also has a “dark side;” the same mutations in makes in the B cell immunoglobulin genes can also lead to tumor growth in cancers like non-Hodgkin’s lymphoma. Even more, non-Hodgkin’s lymphoma tumor cells often overexpress AID on their own, exacerbating the growth of tumor cells.

The study from Rockefeller University investigated the potential of UNG to repair the mutations made in the B cell genome by AID enzymes to prevent the growth of non-Hodgkin’s lymphoma tumors: were AID enzymes targeting the telomeres of B cells? Using mouse models, scientists saw that without UNG, B cell telomere mutations from AID caused the ends of B cell chromosomes to rapidly shorten, drastically reducing the antibody-producing cells’ ability to proliferate.

"UNG can contribute to lymphomagenesis by protecting telomeres from AID-induced damage," said study leader Ramiro Verdun. "We show that cancerous human B cells expressing AID require UNG for proliferation, suggesting that targeting UNG may be a means to delay the growth of AID-positive cancers."

Verdun’s study was recently published in The Journal of Experimental Medicine.
 


Source: The Rockefeller University Press
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 04, 2018
Videos
OCT 04, 2018
Why Do We Have Nightmares With a Fever?
Fever is the body’s response to a threat. When some viruses or bacteria try to enter the body, an immune response begins that can include a sharp ris...
OCT 09, 2018
Immunology
OCT 09, 2018
Complement Function Expands
Additional roles to complement protein C3 have been described in work performed by a team of researchers at the Lund University in Sweden...
OCT 11, 2018
Microbiology
OCT 11, 2018
New Vaccine Protects Against Lassa Fever and Rabies
In Africa, Lassa fever is a significant threat to public health. It is a member of the same family of viruses as Ebola....
NOV 19, 2018
Cell & Molecular Biology
NOV 19, 2018
How Mitochondria can Help the Cell Fight Pathogens
Some pathogens can get around out bodies' natural defense mechanisms. So our body developed a Plan B....
NOV 30, 2018
Microbiology
NOV 30, 2018
C-Section Deliveries Disrupt the Transmission of Microbes From Mom to Baby
From our earliest days, bacteria exert a powerful influence on many aspects of our health....
JAN 15, 2019
Immunology
JAN 15, 2019
Stem Cells: Is a Clean Slate Always a Better Start?
A new USC and Stanford study, conducted in mice, deepens the mystery, showing that successfully transplanted stem cells don't behave "normally" as in a healthy person without a transplant....
Loading Comments...